Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin

Expert Opin Drug Deliv. 2020 Jul;17(7):1049-1058. doi: 10.1080/17425247.2020.1772749. Epub 2020 Jun 16.

Abstract

Background: We hypothesized if phagocytosis of liposomes by macrophages could be mitigated through incorporation of a CD47 mimicry peptide (Self peptide: SP) on the surface of liposomes.

Methods: Thin film hydration method followed by extrusion was used to prepare nanoliposomes, and Dox encapsulation in liposomes was done via remote-loading method. Decorated liposomes with SP peptide (SP-LD) at different peptide densities (300 and 600 peptides on the surface of each liposome) were prepared using a pre-insertion technique. Macrophage cell lines were used to compare the cellular uptake of decorated and unmodified liposomes. For biodistribution studies, tumor-bearing mice received the preparations, and fluorescence signals of Dox in different tissues were measured. To evaluate anti-tumor efficacy, tumor size and survival rates were assessed. Also, pharmacokinetic parameters were determined.

Results: Compared with PEGylated liposomes, uptake by macrophages was largely decreased when SP was incorporated on liposomes. Following intravenous injection, SP-liposomes were cleared more slowly compared with PEGylated liposomes. Eventually, SP-liposomes were highly distributed to tumor tissues compared with PEGylated liposomes, and significantly reduced tumor size and improved the survival of tumor-bearing mice.

Conclusions: This research showed reduced macrophage uptake, increased blood circulation, and enhanced tumor accumulation of liposomes through SP incorporation on the surface of particles.

Keywords: CD47; Nanoliposome; drug delivery; macrophage; phagocytosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / pharmacokinetics
  • CD47 Antigen / metabolism*
  • Cell Line, Tumor
  • Doxorubicin / administration & dosage*
  • Humans
  • Liposomes
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Peptides / metabolism*
  • Polyethylene Glycols / chemistry
  • Tissue Distribution

Substances

  • Antibiotics, Antineoplastic
  • CD47 Antigen
  • CD47 protein, human
  • Liposomes
  • Peptides
  • Polyethylene Glycols
  • Doxorubicin